Overview
- Kyrgios provided a urine sample at the Mallorca Open on June 22, 2026, and a WADA‑accredited lab confirmed the presence of benzoylecgonine, a metabolite of cocaine, on July 17, 2026.
- The International Tennis Integrity Agency applied a mandatory provisional suspension on August 4, 2026, and Kyrgios publicly acknowledged the failed test and apologised on August 19, 2026.
- While the provisional suspension remains in force the 31‑year‑old cannot play, coach at, or attend ATP, WTA or Grand Slam events and has not filed an appeal against that suspension.
- Final sanctions will depend on whether the tribunal finds ingestion occurred in competition, with reduced penalties possible for out‑of‑competition use and potential bans ranging from months to up to four years.
- The case adds immediate competitive and commercial uncertainty to Kyrgios’s injury‑hampered career and reputational standing, and the sport will watch the tribunal process for how tennis applies 'substance of abuse' rules.